PMGC (NASDAQ:ELAB – Get Free Report) and Astronics (NASDAQ:ATRO – Get Free Report) are both industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations.
Profitability
This table compares PMGC and Astronics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PMGC | -522.92% | -118.83% | -60.03% |
| Astronics | 14.21% | 73.50% | 16.59% |
Insider & Institutional Ownership
22.2% of PMGC shares are held by institutional investors. Comparatively, 56.7% of Astronics shares are held by institutional investors. 0.0% of PMGC shares are held by insiders. Comparatively, 8.9% of Astronics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Volatility & Risk
PMGC has a beta of -0.27, suggesting that its share price is 127% less volatile than the S&P 500. Comparatively, Astronics has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500.
Valuation & Earnings
This table compares PMGC and Astronics”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PMGC | $590,000.00 | 2.18 | -$7.75 million | ($1,305.96) | -0.00 |
| Astronics | $862.13 million | 3.01 | $29.36 million | $3.04 | 19.84 |
Astronics has higher revenue and earnings than PMGC. PMGC is trading at a lower price-to-earnings ratio than Astronics, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for PMGC and Astronics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PMGC | 1 | 0 | 0 | 0 | 1.00 |
| Astronics | 0 | 3 | 2 | 2 | 2.86 |
Astronics has a consensus price target of $84.58, indicating a potential upside of 40.25%. Given Astronics’ stronger consensus rating and higher probable upside, analysts plainly believe Astronics is more favorable than PMGC.
Summary
Astronics beats PMGC on 15 of the 15 factors compared between the two stocks.
About PMGC
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
About Astronics
Astronics Corporation designs and manufactures technologies for the aerospace, defense and other industries. Its aerospace products include aircraft lighting, electrical power generation and distribution systems, cabin electronics, connectivity solutions and avionics-related equipment used on commercial and military aircraft. The company also develops test systems, including automated equipment used to test aerospace and defense electronics. Astronics serves aircraft manufacturers, airlines, defense organizations and other customers, with products and services reaching markets around the world.
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
